PHARMAC would like to advise all interested parties that there will be a delay in the decision on a proposal to list ferric carboxymaltose (Ferinject) 500 mg per 10 ml vial in Section H of the Pharmaceutical Schedule from 1 July 2014 for the treatment of iron deficiency anaemia.

The proposal was the subject of a consultation letter dated 16 May 2014 which can be found on PHARMAC’s website.

Consultation on this proposal has now closed. We received a large number of detailed responses during consultation, and we require additional time to fully consider these responses before a decision can be made on the proposal.

This delay will mean that a decision will not be made in time for 1 July 2014 funding changes. We expect a decision to be made, and subsequently notified, on this proposal within the next month.

For more details, go to: http://www.pharmac.health.nz/news/notification-2014-06-20-ferric-carboxymaltose/